As negotiations continue and offers begin to get submitted, word is going to leak out.....it’s only human nature and it’s inevitable.....so, I believe Big Pharma is walking a fine line right now, and for a very limited time, between this beneficially low share price (or should I say, manipulatedly low share price) and the sp we’ll begin to see once word starts to seep between the cracks, and the real buying starts to come in and we start to see valuation a little more in line with, or even much higher than what the analysts are saying. ......all just my own humble opinion and wishful speculation